Scottish tech's frontpage
ayeoh.io

“SaxaVord Spaceport’s £60m has given Scottish space more in October alone than in all of 2025, on our record.”

Sources
The lion rampant
Company · Edinburgh

Trogenix

Trogenix is an edin uni spinout based in Edinburgh, with 1 funding round on the record.

What they do

“These SSEs are engineered DNA elements that are only activated in diseased cell states. SSEs act as docking stations for transcription factors uniquely expressed in aggressive cancer or diseased cells, allowing for highly selective and potent gene control.”

In its own words, on trogenixbio.com

In plain speak

They create engineered DNA elements that turn on only in diseased cells, and use them to control genes selectively in aggressive cancers.

In the news

Trogenix raises £70m to continue developing cancer therapies

BusinessCloud · 6 Oct 2025 · also Scottish Financial Review, Silicon Scotland

Funding rounds

Trogenix raises £70m

6 Nov 2025 · Series A · Edinburgh Innovations · with IQ Capital, 4BIO Capital, Cancer Research Horizons, National Brain Tumour Society, Eli Lilly, Meltwind, LongeVC, Calculus Capital · the round · Scottish tech funding, November 2025

Latest from Trogenix

Turning cancer against itself: Programmable genetic medicines for glioblastoma

1 Jul 2026, from trogenix.com, posted by the company

Editor’s pick: Trogenix

30 Jun 2026, from trogenix.com, posted by the company

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

28 May 2026, from trogenix.com, posted by the company

Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

8 Apr 2026, from trogenix.com, posted by the company

JP Morgan Annual Healthcare Conference 2026, San Francisco

21 Oct 2025, from trogenix.com, posted by the company

Timeline

  1. 1 Jul 2026from the companyTurning cancer against itself: Programmable genetic medicines for glioblastoma
  2. 30 Jun 2026from the companyEditor’s pick: Trogenix
  3. 28 May 2026from the companyTrogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma
  4. 8 Apr 2026from the companyTrogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
  5. 6 Nov 2025fundingSeries A, £70m from IQ Capital, 4BIO Capital, Cancer Research Horizons
  6. 21 Oct 2025from the companyJP Morgan Annual Healthcare Conference 2026, San Francisco
  7. 6 Oct 2025newsTrogenix raises £70m to continue developing cancer therapies

Register facts, funding, grants and the latest news, each linked or sourced. The data file holds the register facts, funding and grants only.

On the record

University of Edinburgh spinout Trogenix dosed the first patient in a Phase I/II trial of its gene therapy for glioblastoma.

28 May 2026 · Edinburgh Innovations

More life sciences companies in Edinburgh

Related

Explore

Life sciences companies in Edinburgh · Life sciences companies in Scotland · Tech companies in Edinburgh · Fastest growing Scottish tech companies · Life sciences sector report · Scottish tech funding report

Today's Scottish tech news on the front page

Every line on this page comes from the record and links to where it was published or filed.

Something to add or correct? Write to ayeoh@loopsio.com and we'll update it.

Is this your company? Claim this page with your work email to send corrections.

Featured on ayeoh? Get the badge for your site.